iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources. The majority of iHuman Inc's revenue comes from mainland China.
2019
783
LTM Revenue n/a
LTM EBITDA n/a
-$56.3M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
iHuman has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, iHuman achieved revenue of $1.0B and an EBITDA of $172M.
iHuman expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See iHuman valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $986M | $1.0B | XXX | XXX | XXX |
Gross Profit | $661M | $691M | XXX | XXX | XXX |
Gross Margin | 67% | 68% | XXX | XXX | XXX |
EBITDA | $122M | $172M | XXX | XXX | XXX |
EBITDA Margin | 12% | 17% | XXX | XXX | XXX |
Net Profit | -$37.1M | $110M | XXX | XXX | XXX |
Net Margin | -4% | 11% | XXX | XXX | XXX |
Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, iHuman's stock price is $2.
iHuman has current market cap of $102M, and EV of -$56.3M.
See iHuman trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
-$56.3M | $102M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, iHuman has market cap of $102M and EV of -$56.3M.
iHuman's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate iHuman's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for iHuman and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | -$56.3M | XXX | XXX | XXX |
EV/Revenue | -0.1x | XXX | XXX | XXX |
EV/EBITDA | -0.3x | XXX | XXX | XXX |
P/E | 0.6x | XXX | XXX | XXX |
P/E/Growth | n/a | XXX | XXX | XXX |
EV/FCF | -0.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpiHuman's NTM/LTM revenue growth is n/a
iHuman's revenue per employee for the last fiscal year averaged $1.3M, while opex per employee averaged $0.7M for the same period.
Over next 12 months, iHuman's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate iHuman's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for iHuman and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 3% | XXX | XXX | XXX | XXX |
EBITDA Margin | 17% | XXX | XXX | XXX | XXX |
EBITDA Growth | 40% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
Revenue per Employee | $1.3M | XXX | XXX | XXX | XXX |
Opex per Employee | $0.7M | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 20% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 10% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | 25% | XXX | XXX | XXX | XXX |
Opex to Revenue | 55% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Alef Education | XXX | XXX | XXX | XXX | XXX | XXX |
Emirates Driving Co. | XXX | XXX | XXX | XXX | XXX | XXX |
51 Talk | XXX | XXX | XXX | XXX | XXX | XXX |
Legacy Education | XXX | XXX | XXX | XXX | XXX | XXX |
3P Learning | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
iHuman acquired XXX companies to date.
Last acquisition by iHuman was XXXXXXXX, XXXXX XXXXX XXXXXX . iHuman acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was iHuman founded? | iHuman was founded in 2019. |
Where is iHuman headquartered? | iHuman is headquartered in United States of America. |
How many employees does iHuman have? | As of today, iHuman has 783 employees. |
Who is the CEO of iHuman? | iHuman's CEO is Mr. Peng Dai. |
Is iHuman publicy listed? | Yes, iHuman is a public company listed on NYS. |
What is the stock symbol of iHuman? | iHuman trades under IH ticker. |
When did iHuman go public? | iHuman went public in 2020. |
Who are competitors of iHuman? | Similar companies to iHuman include e.g. Alef Education, Emirates Driving Co., 51 Talk, Legacy Education. |
What is the current market cap of iHuman? | iHuman's current market cap is $102M |
What is the current revenue growth of iHuman? | iHuman revenue growth between 2023 and 2024 was 3%. |
Is iHuman profitable? | Yes, iHuman is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.